Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / CD Molecules

Recombinant Human CD238/KEL Protein, N-His

Catalog #:   YHD56301 Specific References (49) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P23276
Protein length: Asn68-Ser280
Overview

Catalog No.

YHD56301

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Asn68-Ser280

Predicted molecular weight

26.36 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P23276

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Kell blood group glycoprotein, KEL, CD238

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human CD238/KEL
References

A structure-based in silico analysis of the Kell blood group system., PMID:39726599

Genetic profile of RHCE, Kell, Duffy, Kidd, Diego and MNS hybrid glycophorins blood groups in ethnic northeastern Thais: Alleles, genotypes and risk of alloimmunisation., PMID:38804163

Epigenetic dissection of human blood group genes reveals regulatory elements and detailed characteristics of KEL and four other loci., PMID:38644556

Use of KEL-1 negative red blood cells for emergency release., PMID:37563839

A novel KEL c.1414-1G>T allele in a polish patient with anti-Ku antibody., PMID:35932201

Novel KEL allele associated with loss of Kpb identified in a white blood donor., PMID:35852066

Noninvasive diagnostics of fetal KEL*01.01 allele from maternal plasma of immunized women using digital PCR protocols., PMID:35191535

Functional Evaluation of KEL as an Oncogenic Gene in the Progression of Acute Erythroleukemia., PMID:35140839

Recognizing Impaired Decisional Capacity in Vaccine Refusal: Reply to Kels and Kels., PMID:35120287

Novel KEL*02M allele in Austria encoding a Kmod phenotype., PMID:34910313

Five novel silenced KEL*02 alleles., PMID:34554576

A novel KEL null allele with c.223+1g>t leads to the absence of the Kpb antigen in a First Nation donor., PMID:34310722

Complement Plays a Critical Role in Inflammation-Induced Immunoprophylaxis Failure in Mice., PMID:34249009

Novel KEL*02N allele in Saudi Arabia encoding a Kell null (K0 ) phenotype., PMID:34137046

[Expression of circ-KEL in acute myeloid leukemia and its regulatory mechanisms in leukemic cells]., PMID:33910309

HLA-DRB1 molecules and the presentation of anchor peptides from RhD, RhCE, and KEL proteins., PMID:33675036

An open-source python library for detection of known and novel Kell, Duffy and Kidd variants from exome sequencing., PMID:33567470

The effectiveness of KEL and RHCE fetal genotype assessment in alloimmunized women by minisequencing., PMID:33562967

Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program., PMID:33231305

Poly(I:C) causes failure of immunoprophylaxis to red blood cells expressing the KEL glycoprotein in mice., PMID:32266378

Association between HLA-DRB1*01 and HLA-DRB1*15 with alloimmunisation in transfusion-dependent patients with thalassaemia., PMID:32227529

Do red cell alloantibodies continue to challenge breast fed babies?, PMID:32083382

Low incidence of post-transfusion Kell (KEL1) alloimmunisation in patients under 50 years old., PMID:31769076

Establishment of KEL*01 and KEL*02 Genotyping to Recruit Uncommon, Kell-positive, Reagent Red Cells Among Thai Blood Donors., PMID:31625357

First report of a KELnull phenotype in Peru and a lesson of invisible genetic disparity., PMID:31176642

A novel c.1664G > T(p.Gly555Val) mutation in the KEL gene encoding the Kmod phenotype., PMID:31077392

Mutations in Chromatin Modifier and Ephrin Signaling Genes in Vein of Galen Malformation., PMID:30578106

Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses., PMID:30429364

Transfused platelets enhance alloimmune responses to transfused KEL-expressing red blood cells in a murine model., PMID:30418129

Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies., PMID:29445378

Silent KEL alleles identified from Japanese individuals with the Ko phenotype., PMID:29280152

Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin., PMID:28871080

Antigen Density Dictates Immune Responsiveness following Red Blood Cell Transfusion., PMID:28250159

Three new alleles encoding an apparent Kellnull phenotype., PMID:27861976

An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigens., PMID:27730708

Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice., PMID:27688803

Effect of Irradiation on Microparticles in Red Blood Cell Concentrates., PMID:27139610

New KEL*01M and KEL*02M alleles: structural modeling to assess the impact of amino acid changes., PMID:26996808

Clinically significant anti-KEL RBC alloantibodies are transferred by breast milk in a murine model., PMID:26950259

Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells., PMID:26643781

Clinical Potential of Effective Noninvasive Exclusion of KEL1-Positive Fetuses in KEL1-Negative Pregnant Women., PMID:26492079

NON-INVASIVE MONITORING OF FOETAL ANAEMIA IN KELL SENSITIZED PREGNANCY., PMID:26411147

Kell and Kx blood group systems., PMID:26308465

Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model., PMID:26185172

The prevalence of anti-K in Canadian prenatal patients., PMID:25968929

Acute extravascular hemolytic transfusion reaction due to anti-Kpa antibody missed by electronic crossmatch., PMID:25175412

Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population., PMID:25156717

Provision of KEL1-negative blood to obstetric patients: a 3-year single-institution retrospective review., PMID:25118004

Three missense mutations found in the KEL gene lead to K(mod) or K0 red blood cell phenotypes., PMID:25041236

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human CD238/KEL Protein, N-His [YHD56301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only